apollomed.net (AMEH) - Price-to-Projected Revenue Ratio

Public company logo of Apollo Medical Holdings Inc. (AMEH)

The forward P/S chart for Apollo Medical Holdings (AMEH) demonstrates market expectations, where 0.20 captures the current state of the parameter. Apollo Medical Holdings is modernizing the IT infrastructure of medical networks, optimizing resource procurement to boost profitability. Management is scaling its physician network by implementing value-based care to increase profits. A positive trend is supported by the expansion of the insured base as part of the digital transformation of US healthcare.

Apollo Medical Holdings, Inc. - AMEH Market Cap to Future Revenue Ratio (period 07/04/2022 - 11/15/2026)

Analytical breakdowns for Apollo Medical Holdings

- stock price and consensus target price:
Analysis of all company metrics:Apollo Medical Holdings AMEH
Product sample of apollomed.net

When constructing a long-term portfolio, it is critical to utilize forward multiples to verify asset value. This indicator compares current market capitalization with expected sales volume, allowing for an assessment of the premium paid for future growth, which is particularly relevant for Apollo Medical Holdings (AMEH) given the margin dependency on government Medicare Advantage rates and high costs relative to the expected price-to-sales ratio.

Competitors of Apollo Medical Holdings

Price-to-Projected Revenue Ratio Veeva Corp VEEV|Price to Expected Revenue Ratio DOCS (Doximity, Inc.)|HQY: Forward Price-to-Revenue Multiple|Forward Price to Sales WAY (waystar.com)|CorVel Corp. (CRVL) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Privia Health (PRVA)|Price-to-Projected Revenue Ratio Huron Corp|Market Cap to Projected Revenue CERT (Certara Corp)|Price-to-Projected Revenue Ratio Omnicell (OMCL)|GoodRx Holdings, Inc. - Market Cap to Projected Revenue|Schrödinger - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Phreesia Inc (PHR)|OMDA: Forward Price-to-Revenue Multiple|Forward Price to Sales EVH (Evolent Health, Inc.)|HSTM: Forward P/S Multiple|DH: Price to Expected Revenue Ratio|CCSI (Consensus) - Forward P/S Multiple|Price-to-Projected Revenue Ratio AGL|Forward P/S Multiple ABSI|Market Cap to Expected Sales Ratio So-Young Corp|Price-to-Projected Revenue Ratio National Research NRC|SPOK - Forward Price-to-Revenue Multiple|optimizerx.com - Forward P/S Multiple|Projected Price to Revenue TruBridge (TBRG)|SLP: Forward P/S Multiple|SOPH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HCAT|CCLD (CareCloud) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio researchsolutions.com (RSSS)|DLHC (DLH Holdings) - Forward Price to Sales|Price-to-Projected Revenue Ratio OneMedNet ONMD|SCNX - Forward Price-to-Revenue Multiple|healthcaretriangle.com - Forward P/S Multiple|Market Cap to Future Revenue Ratio ispecimen.com|BFRG: Forward P/S Multiple|Forward Price-to-Revenue Multiple SCWorx Corporation|MSPR (msprecovery.com) - Forward P/S Multiple|Forward Price-to-Revenue Multiple iCoreConnect Inc. (ICCT)|Price-to-Projected Revenue Ratio trxadehealth.com (MEDS)|ORGS (Orgenesis Inc.) - Forward Price to Sales|Price-to-Projected Revenue Ratio r1rcm.com RCM|Forward P/S Multiple Sharecare Inc. SHCR|STRM - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Syra Health Corp. SYRA|Model N (MODN) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue NXGN